Emory Healthcare CEO: What to Expect from Trump's HHS Nominee
Other area execs are mum on Tom Price, MD, who has been an outspoken opponent of specific portions of the PPACA that appear to benefit hospitals.
This is part of a series covering the Shaping of Healthcare's Future in the Trump era.
Despite his career as a physician and six-term 6th-district Georgia Congressional representative, some hospital and health system executives are wary about what to expect from Tom Price, MD, President-elect Trump's nominee for Secretary of Health and Human Services.
Beyond his congressional reputation as a staunch opponent of Obamacare, many don't seem to know much about him or what to expect from Tom Price as HHS Secretary.
The associations in healthcare have been predictably supportive of his nomination, perhaps in hopes that the new HHS secretary will work with them to retool the last administration's signature healthcare accomplishment without hurting their interests too badly.
But individual healthcare organization leaders in his home district of Atlanta—even those who know him personally—don't seem particularly eager to discuss him.
Jonathan Lewin, MD, the president, CEO, and chair of the board of Emory Healthcare, agreed to discuss the nominee. Four other high-profile Atlanta-area health system leaders declined on-the-record interviews.
Perhaps that's at least in part because during his Congressional tenure, Price has been particularly critical of part of the law that requires insurers to offer a government-mandated basic level of coverage as well as a provision that extends federal aid to states in return for their expansion of Medicaid to cover more people.